losartan has been researched along with Neurilemoma in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, L | 1 |
| Vasilijic, S | 1 |
| Sun, Y | 1 |
| Chen, J | 1 |
| Landegger, LD | 1 |
| Zhang, Y | 1 |
| Zhou, W | 1 |
| Ren, J | 1 |
| Early, S | 1 |
| Yin, Z | 1 |
| Ho, WW | 1 |
| Zhang, N | 1 |
| Gao, X | 1 |
| Lee, GY | 1 |
| Datta, M | 1 |
| Sagers, JE | 1 |
| Brown, A | 1 |
| Muzikansky, A | 1 |
| Stemmer-Rachamimov, A | 1 |
| Zhang, L | 1 |
| Plotkin, SR | 1 |
| Jain, RK | 1 |
| Stankovic, KM | 1 |
| Xu, L | 1 |
1 other study available for losartan and Neurilemoma
| Article | Year |
|---|---|
Losartan prevents tumor-induced hearing loss and augments radiation efficacy in NF2 schwannoma rodent models.
Topics: Animals; Hearing Loss; Humans; Losartan; Mice; Neurilemmoma; Neurofibromatosis 2; Prospective Studie | 2021 |